Schedule 13D ownership disclosure

Aspen Neuroscience, Inc.

Common stock, par value $0.0001 per share · CUSIP: 044933109

Event date: 2026-11-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ARCH Venture Fund X, L.P.Reported CIK 0001757011

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Partners X, L.P.Reported CIK 0001782583

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Fund X Overage, L.P.Reported CIK 0001757017

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Partners X Overage, L.P.Reported CIK 0001768905

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Partners X, LLCReported CIK 0001769012

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Fund XIV, L.P.Reported CIK 0002138046

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Partners XIV, L.P.Reported CIK 0002147717

    Shares: 3,754,922 · Class: 12.9%

  • ARCH Venture Partners XIV, LLCReported CIK 0002148927

    Shares: 3,754,922 · Class: 12.9%

  • Robert NelsenReported CIK 0001219042

    Shares: 3,754,922 · Class: 12.9%

  • Keith CrandellReported CIK 0001219039

    Shares: 3,754,922 · Class: 12.9%

  • Kristina BurowReported CIK 0001569248

    Shares: 3,754,922 · Class: 12.9%

  • Steven GillisReported CIK 0001229592

    Shares: 3,754,922 · Class: 12.9%

  • Paul BernsReported CIK 0001202769

    Shares: 1,200,000 · Class: 4.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-454047
Form type
SCHEDULE 13D
Filer
Aspen Neuroscience, Inc.
CIK
CIK 2124080
Filed
Nov 09, 2026
Reporting period
Nov 02, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub